251 related articles for article (PubMed ID: 30101536)
1. Peripheral Th17 cells expressing β7 intestinal homing receptor in recent and chronic HIV infections.
Márquez-Coello M; Montes-de-Oca Arjona M; Fernández-Gutiérrez Del Álamo C; Ruiz-Sánchez C; Girón-González JA
Clin Exp Immunol; 2018 Dec; 194(3):350-360. PubMed ID: 30101536
[TBL] [Abstract][Full Text] [Related]
2. The Th17/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocation.
Chevalier MF; Petitjean G; Dunyach-Rémy C; Didier C; Girard PM; Manea ME; Campa P; Meyer L; Rouzioux C; Lavigne JP; Barré-Sinoussi F; Scott-Algara D; Weiss L
PLoS Pathog; 2013; 9(6):e1003453. PubMed ID: 23818854
[TBL] [Abstract][Full Text] [Related]
3. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART.
DaFonseca S; Niessl J; Pouvreau S; Wacleche VS; Gosselin A; Cleret-Buhot A; Bernard N; Tremblay C; Jenabian MA; Routy JP; Ancuta P
Retrovirology; 2015 Apr; 12():38. PubMed ID: 25924895
[TBL] [Abstract][Full Text] [Related]
4. Expression of gut-homing β7 receptor on T cells: surrogate marker for microbial translocation in suppressed HIV-1-infected patients?
Abad-Fernández M; Gutiérrez C; Madrid N; Hernández-Novoa B; Díaz L; Muñoz-Fernández MA; Moreno S; Vallejo A
HIV Med; 2015 Jan; 16(1):15-23. PubMed ID: 24831847
[TBL] [Abstract][Full Text] [Related]
5. Reconstitution of intestinal CD4 and Th17 T cells in antiretroviral therapy suppressed HIV-infected subjects: implication for residual immune activation from the results of a clinical trial.
d'Ettorre G; Baroncelli S; Micci L; Ceccarelli G; Andreotti M; Sharma P; Fanello G; Fiocca F; Cavallari EN; Giustini N; Mallano A; Galluzzo CM; Vella S; Mastroianni CM; Silvestri G; Paiardini M; Vullo V
PLoS One; 2014; 9(10):e109791. PubMed ID: 25340778
[TBL] [Abstract][Full Text] [Related]
6. Mucosal T Helper 17 and T Regulatory Cell Homeostasis Correlate with Acute Simian Immunodeficiency Virus Viremia and Responsiveness to Antiretroviral Therapy in Macaques.
O'Connor MA; Munson PV; Tunggal HC; Hajari N; Lewis TB; Bratt D; Moats C; Smedley J; Bagley KC; Mullins JI; Fuller DH
AIDS Res Hum Retroviruses; 2019 Mar; 35(3):295-305. PubMed ID: 30398361
[TBL] [Abstract][Full Text] [Related]
7. Treatment-Naïve HIV-Infected Patients Have Fewer Gut-Homing β7 Memory CD4 T Cells than Healthy Controls.
Fadul N; Couturier J; Yu X; Kozinetz C; Arduino R; Lewis DE
South Med J; 2017 Nov; 110(11):709-713. PubMed ID: 29100221
[TBL] [Abstract][Full Text] [Related]
8. Brief Report: A High Rate of β7+ Gut-Homing Lymphocytes in HIV-Infected Immunological Nonresponders is Associated With Poor CD4 T-Cell Recovery During Suppressive HAART.
Girard A; Vergnon-Miszczycha D; Depincé-Berger AE; Roblin X; Lutch F; Lambert C; Rochereau N; Bourlet T; Genin C; Paul S
J Acquir Immune Defic Syndr; 2016 Jul; 72(3):259-65. PubMed ID: 27306505
[TBL] [Abstract][Full Text] [Related]
9. Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals.
Mavigner M; Cazabat M; Dubois M; L'Faqihi FE; Requena M; Pasquier C; Klopp P; Amar J; Alric L; Barange K; Vinel JP; Marchou B; Massip P; Izopet J; Delobel P
J Clin Invest; 2012 Jan; 122(1):62-9. PubMed ID: 22156200
[TBL] [Abstract][Full Text] [Related]
10. Impact of HIV Infection and Anti-Retroviral Therapy on the Immune Profile of and Microbial Translocation in HIV-Infected Children in Vietnam.
Bi X; Ishizaki A; Nguyen LV; Matsuda K; Pham HV; Phan CT; Ogata K; Giang TT; Phung TT; Nguyen TT; Tokoro M; Pham AN; Khu DT; Ichimura H
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27490536
[TBL] [Abstract][Full Text] [Related]
11. Loss of Th22 cells is associated with increased immune activation and IDO-1 activity in HIV-1 infection.
Page EE; Greathead L; Metcalf R; Clark SA; Hart M; Fuchs D; Pantelidis P; Gotch F; Pozniak A; Nelson M; Boasso A; Gazzard B; Kelleher P
J Acquir Immune Defic Syndr; 2014 Nov; 67(3):227-35. PubMed ID: 25314246
[TBL] [Abstract][Full Text] [Related]
12. CD4+ T cells, including Th17 and cycling subsets, are intact in the gut mucosa of HIV-1-infected long-term nonprogressors.
Ciccone EJ; Greenwald JH; Lee PI; Biancotto A; Read SW; Yao MA; Hodge JN; Thompson WL; Kovacs SB; Chairez CL; Migueles SA; Kovacs JA; Margolis LB; Sereti I
J Virol; 2011 Jun; 85(12):5880-8. PubMed ID: 21471231
[TBL] [Abstract][Full Text] [Related]
13. Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration.
Sereti I; Estes JD; Thompson WL; Morcock DR; Fischl MA; Croughs T; Beq S; Lafaye de Micheaux S; Yao MD; Ober A; Wilson EM; Natarajan V; Imamichi H; Boulassel MR; Lederman MM; Routy JP
PLoS Pathog; 2014 Jan; 10(1):e1003890. PubMed ID: 24497828
[TBL] [Abstract][Full Text] [Related]
14. Imbalances of gut-homing CD4+ T-cell subsets in HIV-1-infected Chinese patients.
Peng Q; Wang H; Wang H; Li X; Lu X; Liu L; Zhou B; Chen Z
J Acquir Immune Defic Syndr; 2013 Sep; 64(1):25-31. PubMed ID: 23572009
[TBL] [Abstract][Full Text] [Related]
15. Correlation between different methods to measure microbial translocation and its association with immune activation in long-term suppressed HIV-1-infected individuals.
Abad-Fernández M; Vallejo A; Hernández-Novoa B; Díaz L; Gutiérrez C; Madrid N; Muñoz MA; Moreno S
J Acquir Immune Defic Syndr; 2013 Oct; 64(2):149-53. PubMed ID: 24047967
[TBL] [Abstract][Full Text] [Related]
16. The Architecture of Circulating Immune Cells Is Dysregulated in People Living With HIV on Long Term Antiretroviral Treatment and Relates With Markers of the HIV-1 Reservoir, Cytomegalovirus, and Microbial Translocation.
Van de Wijer L; van der Heijden WA; Ter Horst R; Jaeger M; Trypsteen W; Rutsaert S; van Cranenbroek B; van Rijssen E; Joosten I; Joosten L; Vandekerckhove L; Schoofs T; van Lunzen J; Netea MG; Koenen HJPM; van der Ven AJAM; de Mast Q
Front Immunol; 2021; 12():661990. PubMed ID: 33953724
[TBL] [Abstract][Full Text] [Related]
17. Macrophages accumulate in the gut mucosa of untreated HIV-infected patients.
Allers K; Fehr M; Conrad K; Epple HJ; Schürmann D; Geelhaar-Karsch A; Schinnerling K; Moos V; Schneider T
J Infect Dis; 2014 Mar; 209(5):739-48. PubMed ID: 24133185
[TBL] [Abstract][Full Text] [Related]
18. Impact of intensified antiretroviral therapy during early HIV infection on gut immunology and inflammatory blood biomarkers.
Kim CJ; Rousseau R; Huibner S; Kovacs C; Benko E; Shahabi K; Kandel G; Ostrowski M; Kaul R
AIDS; 2017 Jul; 31(11):1529-1534. PubMed ID: 28463882
[TBL] [Abstract][Full Text] [Related]
19. Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection.
Mak G; Zaunders JJ; Bailey M; Seddiki N; Rogers G; Leong L; Phan TG; Kelleher AD; Koelsch KK; Boyd MA; Danta M
Front Immunol; 2021; 12():688886. PubMed ID: 34135912
[TBL] [Abstract][Full Text] [Related]
20. The effect of timing of antiretroviral therapy on CD4+ T-cell reconstitution in the intestine of HIV-infected patients.
Allers K; Puyskens A; Epple HJ; Schürmann D; Hofmann J; Moos V; Schneider T
Mucosal Immunol; 2016 Jan; 9(1):265-74. PubMed ID: 26129649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
